Sellas Life Sciences I (SLS) Performance Update
- Trading Session: 24 hours period ending 03:07 AM Central Europe on Saturday 24 April 2026.
- Price Movement: Share price fell 6.51 % during the session.
- Current Price: USD 11.54 per share on major exchanges.
- Outstanding Shares: 186 million.
- Market Capitalization: USD 2.5 billion.
- Trading Volume (last 24 h): USD 73.9 million.
- Month‑to‑Date Performance: Down 1.48 % since the previous month‑end.
- Technical Indicator: 200‑day simple moving average is USD 8.36.
- 52‑Week Range: Highest price USD 15.88 (30 June 2026); lowest price USD 1.39 (2 December 2025).
Related Stocks – 24‑Hour Performance
| Ticker | Company | Price Change | Current Price | Market Cap | Notes |
|---|---|---|---|---|---|
| NOG | Northern Oil And Gas | –0.66 % | USD 28.26 | USD 2.9 bn | – |
| ALRM | Alarm | +4.95 % | USD 64.14 | USD 2.9 bn | P/E = 26.34 |
| ACHC | Acadia Healthcare | +1.43 % | USD 31.51 | USD 2.9 bn | – |
| ATRC | Atricure | +2.83 % | USD 58.97 | USD 2.9 bn | P/E = 266.39 |
| IRON | Disc Medicine | –4.38 % | USD 74.51 | USD 2.9 bn | – |
Company Overview
Sellas Life Sciences Group Inc. is a biopharmaceutical company listed on the Nasdaq. The firm focuses on late‑stage oncology drug development and therapies for cancer treatment. It serves patients globally and maintains an online presence at www.sellaslifesciences.com .
